Radiation Oncology: PerspectaRAD

News: Actuality notified of winning Frost & Sullivan Award for Technology Innovation in radiation oncology (North America, 2007)

As seen at ASTRO, PerspectaRAD enhances the therapy planning workflow of your Philips Pinnacle workstations:

• Initial studies suggest that PerspectaRAD can outperform 2-D solutions alone, and 1 of 7 patients received different treatment based on findings. (Chu et al, 2006)
• See anatomy, multiple regions of interest, and dose volumes in hologram-like 3-D
• Find optimum treatment plans by viewing and working directly in 3-D with the SensAble Phantom OMNI 3-D mouse
• Synchronize dose simulations with Pinnacle

Learn more:

• PerspectaRAD information sheet
• Experience the video: Discovery Channel covers initial pre-clinical study of PerspectaRAD at Rush University Medical Center.
• Video of PerspectaRAD: Targeting Cancer in 3D
• Contact us to learn more
• J. Chu et al, "3D Display of Treatment Planning and Anatomy Data: Initial Observation Using a Promising Technical Advance," World Congress on Medical Physics and Biomedical Engineering, IFMBE Proc. 14 1729-1732 (2006).
• X. Gong et al, "Evaluation of a Volumetric Display for Radiation Therapy Treatment Planning," Med. Phys. 33(6), 2209 (2006).

PerspectaRAD is in pre-clinical trials at Rush Univ. Med. Ctr., NEMC, and Rhode Island Hospital. These statements have not been evaluated by the FDA. These technologies are not FDA-approved and may not be used to prevent, treat, diagnose, or cure disease.

Case Study: Cardiac Ultrasound Guide Wire Localization

Stanford University and NASA Ames found that Perspecta is more accurate for guide wire position estimation tasks than best-in-class 2-D displays (Wang et al, 2005).

DICOM Data Viewer: Perspecta Medical

View standard CT, MR, 3-D ultrasound, and PET with Perspecta Medical.

Contact us to learn more